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Transcription-coupled repair (TCR) efficiently removes a variety of
lesions from the transcribed strand of active genes. By allowing
rapid resumption of RNA synthesis, the process is of major impor-
tance for cellular resistance to transcription-blocking genotoxic
damage. Mutations in the Cockayne syndrome group A or B (CSA
or CSB) gene result in defective TCR. However, the exact mecha-
nism of TCR in mammalian cells remains to be elucidated. We found
that CSA protein is rapidly translocated to the nuclear matrix after
UV irradiation. The translocation of CSA was independent of
Xeroderma pigmentosum group C, which is specific to the global
genome repair subpathway of nucleotide excision repair (NER) and
of the core NER factor Xeroderma pigmentosum group A but
required the CSB protein. In UV-irradiated cells, CSA protein colo-
calized with the hyperphosphorylated form of RNA polymerase II,
engaged in transcription elongation. The translocation of CSA was
also induced by treatment of the cells with cisplatin or hydrogen
peroxide, both of which produce damage that is subjected to TCR
but not induced by treatment with dimethyl sulfate, which
produces damage that is not subjected to TCR. The hydrogen
peroxide-induced translocation of CSA was also CSB dependent.
These findings establish a link between TCR and the nuclear
matrix mediated by CSA.
Nucleotide excision repair (NER) is a versatile DNA repairsystem correcting a broad spectrum of DNA damage,
including UV-induced cyclobutane pyrimidine dimers and (6–4)
photoproducts as well as chemical carcinogen-induced lesions
(1). The process of NER involves damage recognition, local
opening of the DNA helix, dual incisions on both sides of the
lesion, removal of the oligonucleotide containing the damage,
gap-filling DNA synthesis, and ligation (2). There are two
subpathways in NER (3). One is transcription-coupled repair
(TCR), which efficiently removes the damage on the transcribed
strand of transcriptionally active genes. The other is global
genome repair (GGR), which occurs throughout the genome
including the nontranscribed strand of active genes.
Xeroderma pigmentosum (XP) is an autosomal recessive
disease characterized by hypersensitivity to sunlight and a high
incidence of skin cancer on sun-exposed skin (1, 4). Cells from
XP patients are hypersensitive to killing by UV irradiation. XP
is classified into seven genetic complementation groups (XP-A
to -G) and a variant form (XP-V) (1). The primary defect in
XP-A to XP-G resides in NER and both TCR and GGR are
defective in XP-A to XP-G except XP-C, in which only GGR is
impaired (4). XP-V has normal NER activity but a defect in
translesion DNA synthesis (5). Cockayne syndrome (CS) is an
autosomal recessive disease that shows diverse clinical symptoms
including photosensitivity, severe mental retardation, and de-
velopmental defects, but no predisposition to UV-induced skin
cancer (6). CS is classified into two genetic complementation
groups (CS-A and CS-B). XP-B patients and certain patients
belonging to XP-D or XP-G show features of CS in addition to
symptoms of XP (XP-BCS, XP-DCS, and XP-GCS) (1, 4).
CS-A and CS-B cells are deficient in TCR but proficient in GGR
(7, 8). Moreover, it has been shown that oxidative damage, such
as 8-oxoguanine and thymine glycol, on the transcribed strand is
removed by TCR, and that TCR of oxidative damage is profi-
cient in normal human, XP-A, XP-D, and XP-G cells, but
deficient in CS-B, XP-BCS, XP-DCS, and XP-GCS cells (9,
10). It has been reported also that TCR of oxidative damage is
partially deficient in CS-A cells when compared with the cells
from normal individual (10). From these results, it is suggested
that TCR is a discrete pathway for the rapid removal of DNA
damage that blocks transcription rather than a subpathway of
NER, and that the CS-specific features result from defects in
TCR of oxidative damage.
All of the XP and CS (XPA to XPG, XPV, CSA, and CSB)
genes have been cloned (4, 11). The core reaction of global NER
in humans has been reconstituted in vitro with purified proteins
(12–14), whereas the molecular mechanism of TCR in NER has
been resolved only in Escherichia coli. The transcription-repair
coupling factor encoded by the mfd gene binds to and displaces
an RNA polymerase arrested at a DNA lesion and then promotes
removal of the damage by recruiting the UvrABC excinuclease
(15). In human cells, CSA and CSB as well as XPB, XPD, XPG,
hMSH2 (16, 17), hMLH1 (16, 17), BRCA1 (18), and XAB2 (19)
are involved in TCR, but the exact mechanism of TCR remains
to be elucidated. It has been reported that the CSA is a 44-kDa
protein with five WD 40 repeats that appears to have the
potential to interact with other proteins. It has been shown that
the CSA protein interacts with XAB2, CSB, and the p44 subunit
of transcription factor IIH (TFIIH) (19, 20). However, CSA
neither binds to RNA polymerase II (RNAP II) (21) nor releases
the stalled RNAP II elongation complex (22). Thus, the function
of the CSA protein in TCR has been obscure. Here we report a
function of CSA relevant to the mechanism of TCR: CSB-
dependent translocation of the CSA protein to the nuclear matrix
after DNA damage, which is known to be subjected to TCR.
Materials and Methods
Cell Lines. The cell lines used in this study were HeLa cells and
simian virus 40 immortalized human fibroblasts; MRC5SV (wild
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type), WI38VA13 (wild type), CS3BESV (CS-A), CS1ANSV
(CS-B), CS1BESV (CS-B), XP2OSSV (XP-A), and XP4PASV
(XP-C). Whole cell extracts were prepared according to pub-
lished protocols (23, 24).
Antibodies. Preparation and affinity purification of the rabbit
polyclonal anti-CSA and anti-CSB antibodies have been de-
scribed previously (24). Anti-hemagglutinin antigen (HA) anti-
body (3F10) was purchased from Roche Diagnostics. Anti-
glucocorticoid receptor (E-20), anti-lamin B (C-20), and anti-
XPA (FL-273) antibodies were from Santa Cruz Biotechnology.
Anti-retinoblastoma antibody was from PharMingen. Anti-
nuclear pore complex (mAb414), anti-RNAP II (8WG16 and
H5) antibodies were from Berkeley Antibody. Anti-XPC anti-
body was provided by F. Hanaoka (Osaka University).
Generation of a Tagged CSA Construct. The CSA cDNA (20) was
obtained via reverse transcription–PCR from human granulo-
cyte RNA. Primers encoding for CSA cDNA (underlined)
flanked by EcoRI sites were used: 5-GCTAGAATTCTAAT-
GCTGGGGTTTTTGTCC-3 and 5-AGTGATGAAGAAG-
GATGAGAATTCTTGG-3. The PCR product was cloned into
pcDNA3 (Invitrogen), resulting in pcDNA3-CSA. Sequencing of
the construct ruled out the presence of PCR-derived mistakes.
For the generation of the tagged CSA construct, full length CSA
cDNA mutated in the stop codon (TGA to TGG) was cloned
in-frame and upstream of a sequence encoding six histidine
residues (His6) followed by a HA epitope in a pBluescript
backbone, yielding pBL-CSA-His6-HA. The part of the cDNA
corresponding to the C terminus of His6-HA-tagged CSA was
isolated by AflII–XbaI digestion and exchanged with the corre-
sponding sequence in the wild-type pcDNA3-CSA, resulting in
pcDNA3-CSA-His6-HA. For simplicity, this construct is re-
ferred to as double-tagged CSA (dtCSA).
DNA Transfection and UV Survival. CS-A fibroblasts (CS3BESV)
were transfected with the pcDNA3-CSA or pcDNA3-dtCSA
construct by using SuperFect transfection reagent (Qiagen,
Chatsworth, CA). After selection with G418 (200 gml), stable
transfectants were selected for UV resistance by irradiation with
4 Jm2 of UV-C for 3 consecutive days. UV survival of the
transfectants was assessed as previously described (24, 25).
DNA Damage Induction and Fractionation of Cellular Proteins. To
examine the translocation of CSA protein induced by DNA
damage, cells were incubated for a period after UV irradiation
(5 Jm2 for NER-deficient cells and 20 Jm2 for NER-proficient
cells). In some experiments, cells were treated with either 100
M cisplatin [cis-diamminedichloroplatinum (II)] for 120 min,
10 mM hydrogen peroxide for 15 min followed by incubation for
60 min in the absence of hydrogen peroxide, or 150 M dimethyl
sulfate (DMS) for 30 min followed by incubation for 60 min in
the absence of DMS. The dose of these chemical agents was
based on previous reports (9, 26, 27).
The cells were harvested by trypsinization, and then cellular
proteins were fractionated as described (28–30), with some
modification. After being washed with PBS, cells were extracted
in cytoskeleton (CSK) buffer [10 mM Pipes, pH 6.8100 mM
NaCl300 mM sucrose3 mM MgCl2], supplemented with 0.5%
(volvol) Triton X-1001 mM DTT1 mM EGTA1 mM
PMSF1 g/ml of leupeptin1 g/ml of pepstatin at 4°C for 10
min. The cytoskeletal frameworks were separated from soluble
proteins by centrifugation at 7,500 g for 3 min (fraction 1). The
pellet was washed twice with a solution containing 250 mM
sucrose and 5 mM MgCl2 (fraction 2) and resuspended with 25
mM TrisHCl, pH 7.4250 mM sucrose5 mM MgCl21 mM
PMSF. Chromatin was solubilized by DNA digestion with 1
mgml of DNase I at 30°C for 1 h. The sample was centrifuged
at 7,500  g for 3 min (fraction 3). The pellet was washed three
times with a low-salt buffer (10 mM TrisHCl, pH 7.40.2 mM
MgCl21 mM PMSF) (fraction 4), extracted consecutively with
the low-salt buffer containing an increasing concentration of
NaCl (0.3, 0.5, and 2.0 M) for 15 min, and centrifuged at 20,000
g for 15 min (fraction 5, 6, and 7 respectively). The high-salt
pellet was finally extracted with the low-salt buffer containing
1% (volvol) Triton X-100 for 15 min and centrifuged at
20,000  g for 15 min (fraction 8). The remaining pellet was
washed twice with the low-salt buffer and solubilized in SDS
PAGE loading buffer (fraction 9).
Immunofluorescence Microscopy. Cells grown on coverslips were
washed twice with PBS and once with CSK buffer and incubated
in CSK buffer supplemented with 0.5% (volvol) Triton X-100
0.5 mM PMSF10 g/ml of leupeptin (the Triton-extraction
buffer) at 20°C for 20 min. In the indicated samples, DNase I
(Roche Diagnostics; Grade II) was added to the above Triton-
extraction buffer at a concentration of 0.2 mgml. Cells were
washed twice with CSK buffer and fixed with 3% paraformal-
dehyde in PBS on ice for 20 min. Cells were then washed with
PBS and treated sequentially with 50, 75, and 95% ethanol on ice
for 5 min each. The samples were then blocked with PBS
containing 5% normal goat serum (blocking buffer) at room
temperature for 30 min and incubated in blocking buffer con-
taining anti-HA (1 gml) and antinuclear pore complex anti-
bodies (0.5 gml) at room temperature for 1 h. For double
immunofluorescence labeling by using anti-HA and anti-RNAP
II antibodies, the samples after incubation in blocking buffer
were incubated in blocking buffer containing anti-HA antibody
first and then in blocking buffer containing anti-RNAP II
antibody (diluted 1:500). Cells were washed three times with PBS
for 5 min, incubated with Alexa Fluor 488-conjugated anti-rat
IgG antibody and Alexa Fluor 568-conjugated anti-mouse IgG
antibody in PBS (diluted 1:500; Molecular Probes) at room
temperature for 1 h, and washed three times with PBS. DNA
staining was performed by incubating in TO-PRO-3 iodide in
PBS (diluted 1:5000; Molecular Probes) at room temperature for
5 min and followed by three washes with PBS. The samples were
examined with an MRC-1024 fluorescence microscopy system
(Bio-Rad).
Results
UV Sensitivity and CSA Expression in the dtCSACS3BESV Cells. We
generated a cDNA construct that expresses CSA protein con-
taining a His6 and a HA epitope at the C terminus (dtCSA) and
transfected CS3BESV (CS-A) cells with it. To verify that the
addition of the His6 and HA tags did not interfere with CSA
function, we determined the relative UV sensitivity of the
dtCSA-transfected CS3BESV (dtCSACS3BESV) cells. We
found that the UV survival of the dtCSACS3BESV cells was
similar to that of the MRC5SV (wild type) cells and the
nontagged CSA-transfected CS3BESV (CSACS3BESV) cells
(Fig. 6A, which is published as supporting information on the
PNAS web site, www.pnas.org). Immunoblot analysis by using
anti-CSA antibody indicated that the expression of dtCSA in the
dtCSACS3BESV cells was similar to that of the endogenous
CSA in HeLa cells, and anti-HA antibody was also able to detect
dtCSA protein in the dtCSACS3BESV cells (Fig. 6B, which is
published as supporting information on the PNAS web site).
Translocation of CSA Protein in UV-Irradiated Cells. To gain an
insight into the function of CSA protein, we examined whether
UV-irradiation changes the subcellular localization of the pro-
tein. We fractionated cellular proteins from UV- and nonirra-
diated dtCSACS3BESV cells with serial extractions by using
different concentrations of salt and detergent and analyzed the
localization of dtCSA protein by immunoblotting with anti-HA
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antibody (Fig. 1). In the nonirradiated cells, CSA protein was
mainly detected in the fraction extracted with 0.5% Triton X-100
and in the wash fraction (lanes 1 and 2). Some of the CSA protein
was detected in the DNase I-digested fraction (lane 3) and a very
small amount in the fraction extracted with 0.3 M NaCl (lane 5).
In the cells immediately after UV irradiation, the CSA protein
was detected in the fractions extracted with salt (lanes 5–7) and
1% Triton X-100 (lane 8) besides the 0.5% Triton-soluble and
DNase I-digested fractions (lanes 1–3) and was also detected in
the remaining fraction resistant to high salt, DNase I, and high
Triton, which we henceforth designate as ‘‘nuclear matrix’’
fraction (lane 9). Shortly after UV irradiation (15–30 min), this
shift became more pronounced, whereas in the cells incubated
for 60–180 min after UV irradiation, the CSA protein was
detected mostly in the nuclear matrix fraction (lane 9) and in the
0.5% Triton-soluble fraction (lane 1). Essentially the same
results were obtained from experiments with a lower dose (8
Jm2) of UV (data not shown). These results indicate that part
of the CSA protein was translocated to the nuclear matrix
fraction after UV irradiation.
It has been reported that the XPG protein is redistributed in
the nucleus after UV irradiation (31) and the XPA protein
associates more tightly with genomic DNA after UV irradiation
(29). Therefore, we examined whether the subcellular localiza-
tion of other DNA repair proteins changes after UV irradiation.
(Fig. 7, which is published as supporting information on the
PNAS web site). The XPA protein was detected only in the 0.5%
Triton-soluble fraction in the nonirradiated cells, whereas it was
also detected in the 0.3 M NaCl fraction in the UV-irradiated
cells. These results were consistent with the previously described
finding (29). It has been reported that the CSB protein interacts
with the in vitro translated CSA protein (20) but not with CSA
protein in vivo (24). In our present experimental conditions, the
subcellular translocation of CSB protein was not evident after
UV irradiation. In addition, the subcellular localization of XPC
protein did not change. Although part of RNAP II was detected
in the nuclear matrix fraction, the subcellular localization was
not influenced by UV irradiation. Because RNAP II is involved
in transcription as well as in DNA repair, the majority located in
the nuclear matrix fraction may be involved in transcription.
Thus, among the repair proteins tested in this study, CSA protein
was the only one that was clearly translocated to the nuclear
matrix fraction after UV irradiation.
Our fractionation procedures were validated by comparison
with the distribution of glucocorticoid receptor, Rb protein, and
lamin B (data not shown). The localization of these proteins was
consistent with the one in a previous report (30).
Immunofluorescence Analysis of CSA Protein in the UV-Irradiated
Cells. The localization of CSA protein in the UV-irradiated cells
was also examined by immunofluorescence analysis. An asyn-
chronous population of dtCSACS3BESV cells was irradiated
with UV. Two hours after UV irradiation, cells were perme-
abilized with a buffer containing 0.5% Triton X-100 before
fixation, and the subcellular localization of CSA protein was
monitored by immunofluorescence by using anti-HA rat mono-
clonal antibody (Fig. 2A). The entire cell population displayed
strong nuclear staining for CSA protein that was resistant to the
Triton extraction, and the staining patterns of CSA protein were
not homogeneous in nuclei, with a diffuse nucleoplasmic stain-
ing and foci. On the other hand, the nonirradiated cells did not
Fig. 1. UV-induced translocation of CSA protein to the nuclear matrix in
dtCSACS3BESV cells. Asynchronous cells were irradiated with 20 Jm2 of UV
or nonirradiated and incubated for the indicated period, and then the cellular
extracts were prepared as described in Materials and Methods. Proteins from
each fraction with equivalent cell numbers were loaded for SDSPAGE and
analyzed by immunoblotting with anti-HA antibody. The lane numbers cor-
respond to the fraction numbers.
Fig. 2. Immunofluorescence staining of CSA protein in dtCSACS3BESV cells
after UV irradiation. (A) Asynchronous dtCSACS3BESV cells were irradiated
with 20 Jm2 of UV (UV) or nonirradiated (UV) and treated with the
Triton-extraction buffer before fixation. The CSA protein was detected with
anti-HA rat monoclonal antibody and visualized with Alexa Fluor 488-
conjugated anti-rat IgG antibody (green). DNA was shown by TO-PRO-3
staining (dark-red). (B) Asynchronous dtCSACS3BESV cells were irradiated
with 20 Jm2 of UV and treated with Triton-extraction buffer supplemented
with or without 0.2 mgml of DNase I before fixation. The CSA protein was
detected as described. Nuclear pore complex was detected with antinuclear
pore complex antibody and visualized by Alexa Fluor 568-conjugated anti-
mouse IgG antibody (red).
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show any immunofluorescence in their nuclei. When cells were
not extracted by Triton before fixation, CSA protein was uni-
formly stained in the nuclei, and the intensity of the CSA staining
was the same in both UV and nonirradiated cells (data not
shown). To exclude the possibility that the CSA protein may
associate tightly to DNA after UV irradiation, the UV-irradiated
dtCSACS3BESV cells were treated with DNase I in the pres-
ence of 0.5% Triton X-100 (Fig. 2B). No significant difference
in the staining of CSA protein was detected between DNase
I-treated and untreated cells, although DNA was completely
digested in the treated cells as shown by no reactivity to
TO-PRO-3 iodide. On the other hand, nuclear pores in the
nuclear envelope were preserved during DNase I treatment, as
shown by reactivity to antinuclear pore complex antibody, ver-
ifying the integrity of the nuclear matrix even after DNase I
treatment. These results indicate that the CSA protein is asso-
ciated with nuclear matrix but not directly with DNA after UV
irradiation.
CSA Protein Was Not Translocated in CSB Cells After UV Irradiation.
We then examined the translocation of CSA protein after UV
irradiation in NER-deficient cells (Fig. 3A). The XP2OSSV
(XP-A) cells are deficient in both TCR and GGR. The
XP4PASV (XP-C) cells are selectively deficient in GGR,
whereas the CS1ANSV and CS1BESV (both are CS-B) cells are
selectively defective in TCR. The CSA protein was translocated
to the nuclear matrix fraction 60 min after UV irradiation in the
XP-A and the XP-C cells as well as in the normal human cells
(WI38VA13). In normal cells, the CSA protein was detected in
the nuclear matrix fraction even 12 h after UV irradiation (data
not shown). In contrast, the translocation of the CSA protein did
not occur in two different CS-B cell lines (Fig. 3A and data not
shown). The CSA protein was not detected in the nuclear matrix
fraction even 180 min post UV incubation in CS-B cells (Fig. 3B
and data not shown). However, the CS-B cells stably expressing
double-tagged CSB cDNA (dtCSBCS1ANSV), which were
proficient in TCR (24), resumed normal CSA translocation to
the nuclear matrix fraction after UV irradiation. These results
indicate that the UV-induced translocation of the CSA protein
to the nuclear matrix fraction depends on the CSB protein.
Colocalization of CSA Protein with the Hyperphosphorylated Form of
RNAP II in the UV-Irradiated Cells. It has been reported that the
hyperphosphorylated form of RNAP II, which is essential for
transcriptional elongation, interacts with the nuclear matrix
(32–34). Furthermore, NER may also occur in association with
the nuclear matrix (35–38). We therefore examined whether
RNAP II and CSA protein were colocalized in the nuclear matrix
(Fig. 4). The dtCSACS3BESV cells were incubated for 120 min
after UV irradiation and permeabilized with a buffer containing
Triton X-100 and DNase I before fixation. The localization of
RNAP II and CSA protein in same cells was monitored with
anti-RNAP II monoclonal antibody [hypophosphorylated form
(IIa) and hyperphosphorylated form (IIo) detected by 8WG16,
and IIo detected by H5] and anti-HA rat monoclonal antibody,
respectively. CSA protein was almost completely colocalized
with RNAP II foci detected by H5 but only partially colocalized
with RNAP II foci detected by 8WG16. These results suggest
that CSA protein cooperates with the hyperphosphorylated form
of RNAP II at the nuclear matrix in the process of TCR.
Translocation of CSA Protein to the Nuclear Matrix by Other DNA
Damage That Is Subjected to TCR. To further elucidate the rela-
tionship between translocation of CSA protein to the nuclear
matrix and the TCR process, we examined the effect of other
DNA-damaging agents such as cisplatin, hydrogen peroxide, and
DMS on the translocation of CSA protein. Intrastrand crosslinks
induced by cisplatin and thymine glycol induced by hydrogen
peroxide are known to be removed by TCR similar to UV
damage (9, 27). In contrast, DMS-induced lesions (7-
methylguanine and 3-methyladenine) are efficiently repaired by
global base excision repair (BER) and not subjected to TCR
(26). As shown in Fig. 5A, CSA protein was translocated to the
nuclear matrix fraction on treatment of the cells with cisplatin or
hydrogen peroxide but not with DMS. Moreover, the translo-
cation of CSA protein did not occur in the hydrogen peroxide-
treated CS-B cells but did occur in XP-A, XP-C, and dtCSB
CS1ANSV cells (Fig. 5B). Thus the hydrogen peroxide-induced
translocation of CSA protein to the nuclear matrix fraction also
depended on the CSB protein. All these results indicate that the
translocation of CSA protein to the nuclear matrix fraction
occurs in connection with TCR.
Discussion
We found that CSA protein was rapidly translocated to the
nuclear matrix after UV irradiation (Figs. 1 and 2) and that the
translocation was independent of XPC and XPA but required
CSB protein (Fig. 3). In mammalian cells, the XPChHR23B
complex serves as a damage sensor to initiate GGR and recruits
the core NER machinery to the lesion (39, 40). The DNA around
Fig. 3. Translocation of CSA protein to the nuclear matrix in DNA repair-
deficient cell lines following UV-irradiation. (A) The XP-A (XP2OSSV), XP-C
(XP4PASV), and CS-B (CS1ANSV) cells, which are deficient in NER, were irra-
diated with 5 Jm2 of UV, whereas the wild-type (WI38VA13) cells and the
CS1ANSV cells expressing the dtCSB construct (dtCSBCS1ANSV), which are
proficient in NER, were irradiated with 20 Jm2 of UV. Each fraction was
prepared from cells that were incubated for 60 min after UV irradiation or
from nonirradiated cells and then immunoblotted with anti-CSA antibody.
The lane numbers correspond to the fraction numbers. (B) The nuclear matrix
fraction was prepared from UV-irradiated cells after incubation for the period
indicated, and the translocation of CSA protein to the nuclear matrix was
examined by immunoblotting with anti-CSA antibody.
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the lesion is then opened in an ATP-dependent manner by the
general transcription factor TFIIH, which contains XPB and
XPD helicases. Open complex formation also depends on the
presence of XPA and RPA (41). The XPA protein verifies the
damage in an open DNA conformation and is crucial for proper
orientation of the remainder of the NER machinery. These
results indicate that the UV-induced translocation of CSA
protein to the nuclear matrix fraction is relevant neither to the
GGR-specific step(s) nor to the core NER reactions. On the
other hand, the genetic and cell biological evidence indicates that
the CSA and CSB proteins are involved in the TCR-specific
step(s), although the exact mechanism of TCR in mammalian
cells is unknown as yet. Our results therefore suggested that the
UV-induced translocation of CSA protein to nuclear matrix is
specifically related to the TCR process.
It has been reported that oxidative DNA damage such as
thymine glycol and 8-oxoguanine is removed by TCR that does
not involve NER (9). To verify that the translocation of CSA
protein to the nuclear matrix is also related to TCR of oxidative
damage, we examined the effect of hydrogen peroxide on the
translocation of CSA as well as cisplatin and DMS, which
produce damage that is subjected to NER and BER, respectively.
It has been shown that the damage on the transcribed strand
induced by cisplatin or hydrogen peroxide is removed by TCR,
but the damage by DMS is not (9, 26, 27). We found that the
translocation of CSA was induced by treatment of the cells with
cisplatin or hydrogen peroxide but not by treatment with DMS
(Fig. 5A). In addition, the hydrogen peroxide-induced translo-
cation of CSA was also CSB-dependent (Fig. 5B). These results
strongly suggest that the translocation of CSA to the nuclear
matrix is relevant not only to TCR in NER but also to TCR of
oxidative DNA damage. The mechanisms of the two TCR
processes are expected to be much the same. Presumably, the
elongating RNAP II complex that encounters a lesion detects the
DNA damage early in the TCR pathway. The actual repair
proteins involved in either NER or BER are then recruited, and
the lesion is repaired. The transcription is resumed when the
lesion has been repaired. Consistent with this model, CSA
protein was colocalized with the hyperphosphorylated form of
RNAP II, which is engaged in transcription elongation in
UV-irradiated cells (Fig. 4).
Our results revealed that the CSA protein was translocated to
the nuclear matrix, whereas most of the CSB protein was
detected in the 0.5% Triton-soluble and DNase I-digested
fractions and not in the nuclear matrix fraction following DNA
damage (Fig. 7, which is published as supporting information on
the PNAS web site). Although this finding does not indicate a
direct involvement of CSB in the recruitment of CSA to the
nuclear matrix on DNA damage, it does not exclude the possi-
bility of transient interactions or an indirect role. On the other
hand, the CSB protein interacts with RNAP II and can stimulate
transcriptional elongation (42). In addition, it counteracts
TFIIS-induced transcript shortening (42) but does not dissociate
the stalled RNAP II from DNA (22). It has been shown that CSB
interacts with a ternary complex containing DNA, RNA and
stalled RNAP II in a manner that requires ATP hydrolysis, and
Fig. 4. CSA protein was colocalized with the hyperphosphorylated form of RNAP II in the nuclear matrix after UV irradiation. Asynchronous dtCSACS3BESV
cells were irradiated with 20 Jm2 of UV and treated with Triton X-100 and DNase I before fixation. CSA protein was detected with anti-HA rat monoclonal
antibody and visualized with Alexa Fluor 488-conjugated anti-rat IgG antibody (green; Top). RNAP II was detected with anti-RNAP II monoclonal antibodies (IIo
by H5, IIa  IIo by 8WG16) and visualized with Alexa Fluor 568-conjugated anti-mouse IgG antibody (red; Middle). Merged images are displayed (Bottom).
Fig. 5. Translocation of CSA protein to the nuclear matrix by chemical agents
whose damage is subjected to TCR. (A) The dtCSACS3BESV cells were irradi-
ated with 20 Jm2 of UV and incubated for 60 min or treated (incubated) with
DNA damaging agents (100 M cisplatin; 10 mM hydrogen peroxide; 150 M
DMS). Each fraction was prepared from cells and then immunoblotted with
anti-HA antibody. The lane numbers correspond to the fraction numbers. (B)
XP-A (XP2OSSV), XP-C (XP4PASV), CS-B (CS1ANSV), wild-type (WI38VA13)
cells, and CS1ANSV cells expressing the dtCSB construct (dtCSBCS1ANSV)
were treated with 10 mM hydrogen peroxide and then immunoblotted with
anti-CSA antibody. The lane numbers correspond to the fraction numbers.
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that the quaternary complex can recruit TFIIH (21, 43). These
results suggest that in the TCR subpathway, the CSB protein
interacts with a stalled RNAP II elongation complex and plays
an important role in recruiting TFIIH to the site of a DNA
lesion. Moreover, CSB is able to remodel chromatin structure at
the expense of ATP hydrolysis (44). Thus the CSB protein may
induce conformational changes in the stalled RNAP II complex
or in the surrounding nucleosome structure during TCR. The
conformational changes in the stalled RNAP II complex andor
the alterations of nucleosome structure induced by CSB may
allow the CSA protein to translocate to the nuclear matrix, where
transcription elongation and TCR occur. It may also make the
DNA lesion on the transcribed strand accessible to actual repair
factors.
The nuclear matrix is thought to play an important role in
chromatin organization by providing the axis where complex
arrays of chromatin loops are anchored. Additionally, the nu-
clear matrix is implicated in nuclear metabolism including DNA
replication, transcription, and mRNA splicing. As for repair,
enrichment of UV-induced repair patches in nuclear matrix
fractions has been reported. Interestingly, this phenomenon was
enhanced in TCR-proficient XP-C cells and abolished in TCR-
deficient CS-B fibroblasts (45). These findings indicate that TCR
takes place in the nuclear matrix, consistent with the present
results.
In conclusion, our findings provide evidence that the involve-
ment of CSA in TCR depends on CSB, and that CSA acts at a
stage before actual repair factors, highlight a direct link between
TCR and the nuclear matrix, and suggest that the protein
complex required for TCR is not preassembled but may rapidly
form when transcription elongation has been arrested.
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